Table 3.

The correlation between the postoperative systemic inflammatory response and the clinicopathological factors

	Postoperative NLR			Postoperative GPS
	<3	≥3	p value	0	1,2	p value
Age (years)
<70	120	19		102	28
≥70	63	15	0.331	57	18	0.729
Gender
Male	97	24		84	27
Female	86	10	0.063	75	19	0.506
Location
Colon	93	19		86	22
Rectum	90	15	0.709	73	24	0.504
Tumor depth
T1-3	133	22		112	33
T4	49	12	0.406	47	13	1.000
Histological type
Well, moderately	170	31		147	43
Poorly, mucinous	12	3	0.711	12	2	0.739
Lymphatic involvement
Negative	39	5		35	3
Positive	124	27	0.363	112	37	0.026
Venous involvement
Negative	123	24		109	35
Positive	46	9	1.000	41	8	0.321
Number of lymph node metastases
0	75	8		60	7
1–3	71	19		64	30
≥4	37	7	0.116	35	9	0.005
Preoperative CEA (>5 ng/ml)
Negative	129	25		116	29
Positive	38	6	0.816	35	8	1.000
Preoperative CA19-9 (>37 U/ml)
Negative	158	28		145	33
Positive	5	2	0.298	3	4	0.031
Adjuvant chemotherapy
No	40	4		35	8
Yes	143	30	0.246	124	28	0.545
Length of operation (min)
Median (range)	199 (79–430)	230 (84–687)	0.010	203 (79–687)	206 (110–372)	0.681
Blood loss (ml)
Median (range)	80 (5–1785)	220 (10–2700)	<0.001	80 (5–2700)	90 (10–1880)	0.495
Postoperative infectious complication
No	137	25		121	34
Yes	46	9	0.833	38	12	0.846
Preoperative NLR
<2.5	70	12
≥2.5	45	8	1.000
Preoperative GPS
0				131	21
1,2				24	20	<0.001

NLR neutrophil-to-lymphocyte ratio, GPS Glasgow prognostic score, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19-9